Teleflex Incorporated Common Stock (TFX)
134.17
0.00 (0.00%)
Teleflex Inc is a global provider of medical technology products that enhance the ability of healthcare professionals to provide high-quality patient care
The company develops a wide range of innovative solutions across various medical specialties, including surgical, critical care, and respiratory applications. Teleflex focuses on the design, manufacturing, and commercialization of devices and instruments that improve procedural outcomes, facilitate patient recovery, and enhance safety in both hospital and outpatient settings. With a commitment to advancing medical technologies, Teleflex aims to meet the evolving needs of healthcare providers and patients worldwide.

Via Benzinga · March 4, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Monday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · March 3, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · March 3, 2025

When you look at TELEFLEX INC (NYSETFX), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
Via Chartmill · March 3, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Friday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · February 28, 2025

In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Friday's session.
Via Chartmill · February 28, 2025

Shares of medical technology company Teleflex (NYSETFX)
fell 22.9% in the morning session after the company reported disappointing fourth-quarter results, with revenue missing expectations by a significant margin. On a constant currency basis, revenue increased 3.2%, but this still fell short of Wall Street's estimates. Weak demand in Interventional Urology wiped out gains in the Interventional and Surgical units. Looking ahead, the company's 2025 revenue guidance implies little to no growth, with management projecting revenue to be flat to slightly up. Overall, this was a weaker quarter, weighed down by sluggish growth, margin pressures, and a subdued outlook.
Via StockStory · February 27, 2025

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Thursday as we examine the latest happenings in today's session.
Via Chartmill · February 27, 2025

Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Thursday. Stay informed about the market activity below.
Via Chartmill · February 27, 2025

Let's delve into the developments on the US markets in the middle of the day on Thursday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Via Chartmill · February 27, 2025

Medical technology company Teleflex (NYSETFX) missed Wall Street’s revenue expectations in Q4 CY2024 as sales rose 2.8% year on year to $795.4 million. Its non-GAAP profit of $3.89 per share was in line with analysts’ consensus estimates.
Via StockStory · February 27, 2025

Stocks are seeing plenty of volatility today.
Via Talk Markets · February 27, 2025

Stay updated with the S&P500 gap up and gap down stocks on Thursday. Get a glimpse of the market's movement during today's session.
Via Chartmill · February 27, 2025

Curious about the S&P500 stocks that are showing activity before the opening bell on Thursday?
Via Chartmill · February 27, 2025

Teleflex to separate into two companies by mid-2026 and acquire Biotronik's Vascular Intervention unit for €760 million. CFO Thomas Powell to retire in April.
Via Benzinga · February 27, 2025

Medical technology company Teleflex (NYSETFX)
will be reporting earnings tomorrow before market open. Here’s what to look for.
Via StockStory · February 26, 2025